Medical News

RSS

Top 10 U.S.hospitals prefer Arctic Sun temperature management system

The number of Arctic Sun(R) users among hospitals ranked top 20 jumped to 90 percent this year from 72 percent last year, Medivance announced today. All top 10 "best hospitals" prefer the ease and safety of its advanced non-invasive method for rapid, controlled temperature reduction followed by slow rewarming.

9 Sep 2009

ETS to review RWJF New Careers in Nursing Scholarship Program

Educational Testing Service today announced that the Robert Wood Johnson Foundation approved a $299,827 award to ETS for the purpose of evaluating the RWJF New Careers in Nursing Scholarship Program. The grant period will run from July 15, 2009 to January 15, 2012.

9 Sep 2009

INSPIRE Phase I/IIa study data to be presented at ICAAC

Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced that data from an interim analysis of its INSPIRE Phase I/IIa study of HIV-infected patients with low CD4 T cell counts treated with a three injection cycle of the Company’s investigative immune-modulator, recombinant human Interleukin-7 (CYT107), will be presented during an oral late breaker session at the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), to be held September 12-15, 2009, in San Francisco, CA.

9 Sep 2009

Physicians to educate Congress on the importance of reducing viral hepatitis

The National Viral Hepatitis Roundtable (NVHR) is hosting a briefing, "The Experts' Perspective: Gaps and Strategies in the Hepatitis Crisis." "Leading hepatitis physicians, one of whom is a Congressman, will be on the hill today to educate Congress on the importance of developing a strategy to reduce the significant morbidity and mortality from end-stage liver disease and liver cancer caused by chronic hepatitis B and chronic hepatitis C in the United States," said Martha Saly, Director of NVHR.

9 Sep 2009

GENova Biotherapeutics discusses its anti-cancer drug development strategy

GENova Biotherapeutics, Inc., ("GENova"), today released important information about its anti-cancer drug development strategy and its unique niche in the drug development industry.

9 Sep 2009

aTyr Pharma expands intellectual property portfolio, receives its fifteenth patent

aTyr Pharma announced today that the US Patent office has issued patent US 7,572,452 B2, titled "Method for Stimulating Wound Healing." aTyr Pharma is the sole assignee of this patent, and Professor Sunghoon Kim, a scientific co-founder of aTyr Pharma, is the inventor.

9 Sep 2009

Neuralstem's patent on neural stem cell transplantation approved

Neuralstem, Inc. today announced that it has received notice of allowance from the United States Patent and Trademark Office (USPTO) for its patent entitled “Transplantation of Human Neural Cells For Treatment Of Neurodegenerative Conditions,” number 11/281,640.

9 Sep 2009

U.S. Navy and Solazyme to develop algae-derived advanced biofuel

Solazyme, Inc., the renewable oil production company and leader in algal synthetic biology, has been selected by the U.S. Department of Defense (DoD) to research, develop, and demonstrate commercial scale production of algae-derived advanced biofuel that meets the United States Navy’s rigorous specifications for military tactical platforms.

9 Sep 2009

Health insurance and pharmaceutical industries blamed for problems in the current healthcare system

Whatever the public may think about proposals for health care reform, they blame many different parties for the problems with the system we have now. The health insurance and pharmaceutical industries are the most widely blamed, with most people believing they deserve a “great deal of blame.” However, more than 60% of all adults believe that both Republicans and Democrats in Congress, business, hospitals, former President George W. Bush and doctors should all get at least some blame.

9 Sep 2009

SupportSight free seminar for people affected by macular degeneration

Chester County Eye Care Associates has joined with the Macula Vision Research Foundation (MVRF) to sponsor a SupportSight seminar in West Chester on September 26th.

9 Sep 2009

Campaign launched to tackle childhood obesity

Urging children to get at least 60 minutes of physical activity each day, Pennsylvania Health Secretary Everette James and Education Secretary Gerald Zahorchak today helped to kick off the NFL Play 60 national youth health and fitness campaign.

9 Sep 2009

Synexus on track to double its clinical trial capacity in South Africa, opens two new research centres in Pretoria

Manchester-based Synexus, the world’s largest multi-national company dedicated to the recruitment and running of clinical trials, celebrated the first phase of its South African expansion programme in Pretoria today.

From AES - Accelerated Enrollment Solutions 9 Sep 2009

Successful results on Surinate Bladder Management System

Urovalve announced today the successful results of a feasibility study of the Valve component of its Surinate® Bladder Management System—designed to improve the quality of life of men who suffer from acute or chronic urinary retention, which is an inability to empty the bladder caused by obstruction of the urethra.

9 Sep 2009

Health reform proposals under consideration to benefit small business owners and employees most: Report

Small business owners and employees are among those who stand to benefit the most from provisions in some of the current health reform proposals under consideration by Congress according to a Commonwealth Fund report released today.

9 Sep 2009

Syneron Medical to merge with Candela Corporation

Syneron Medical Ltd. (NASDAQ:ELOS) and Candela Corporation (NASDAQ:CLZR) announced today that they have entered into a definitive agreement to combine the companies in an all stock transaction. This strategic combination, unanimously approved by the Boards of Directors of both companies, will create a global leader in medical aesthetic devices. The transaction is expected to be completed by year-end 2009.

9 Sep 2009

Negotiations on to acquire up to 50% of Vanguard Pharmaceutical by Renato Corporation

Renato Corporation (FRANKFURT: 4OZ) has entered into negotiations to acquire up to 50% of Vanguard Pharmaceutical Corporation. "By acquiring Vanguard, Renato Corporation will have an existing infrastructure in place to market its generic pharmaceuticals to Latin and South America," said Mr. Morkunas.

9 Sep 2009

Congress urged to include injury prevention in health care reform

A group of 18 research centers, professional organizations and advocacy groups have joined together to urge Congress to include injury prevention in health care reform. Each day, 475 Americans die from injuries related to motor vehicle crashes, assaults, fires and other trauma. This results in 170,000 deaths every year, more than twice that from diabetes and more than four times that of breast cancer.

9 Sep 2009

PDL BioPharma announces revenue guidance for the third quarter ended September 30, 2009

PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) today announced revenue guidance for the third quarter ended September 30, 2009 of approximately $71 million, as compared with $69 million for the third quarter of 2008. Royalty revenues are based on second quarter product sales by PDL's licensees and include $1.6 million for Synagis(R), which is marketed by MedImmune.

9 Sep 2009

Sequoia Hospital completes 1000 atrial fibrillation ablation procedures

Sequoia Hospital announced that the Cardiac Arrhythmia Program has completed 1,000 atrial fibrillation (A-Fib) ablation procedures, making it the highest total volume A-Fib ablation institution currently performing ablations in Northern and Central California.

9 Sep 2009

Research study on memory formation and storage process in the human brain

A new study that was carried out at the University of Haifa has identified another component in the chain of actions that take place in the neurons in the process of forming memories. This discovery joins a line of findings from previous studies that together provide a better understanding of the most complex processes in nature - the process of memory formation and storage in the human brain. The new study has been published in the prestigious Journal of Neuroscience.

9 Sep 2009